Statements (55)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:healthcare_organization
|
| gptkbp:affects |
long COVID
economic recovery challenges changes in healthcare delivery |
| gptkbp:caused_by |
gptkb:SARS-Co_V-2
|
| gptkbp:community_impact |
gptkb:historical_event
mental health issues school closures remote work increase |
| gptkbp:cultural_impact |
changes in consumer behavior
virtual events increased online entertainment |
| gptkbp:defense |
gptkb:initiative
Emergency Committee Global Vaccination Strategy |
| gptkbp:economic_impact |
global recession
|
| gptkbp:established |
gptkb:World_Health_Organization
|
| gptkbp:future_plans |
pandemic preparedness
public health policy changes global health cooperation |
| gptkbp:government_type |
public health campaigns
emergency declarations stimulus packages |
| gptkbp:healthcare |
gptkb:quarantine_measures
contact tracing travel restrictions |
| https://www.w3.org/2000/01/rdf-schema#label |
The COVID-19 Pandemic
|
| gptkbp:is_protected_by |
hand hygiene
mask-wearing social distancing |
| gptkbp:is_recognized_by |
gptkb:Wuhan,_China
|
| gptkbp:is_vulnerable_to |
viral vector vaccines
inactivated virus vaccines m RNA vaccines |
| gptkbp:launch_date |
December 2019
|
| gptkbp:media_coverage |
social media discussions
extensive news reporting |
| gptkbp:propagation_method |
respiratory droplets
|
| gptkbp:research |
vaccine efficacy studies
transmission studies treatment trials |
| gptkbp:symptoms |
cough
fever shortness of breath loss of taste or smell |
| gptkbp:treatment |
supportive care
monoclonal antibodies antiviral drugs |
| gptkbp:variant |
gptkb:Alpha_variant
gptkb:Delta_variant Omicron variant |
| gptkbp:bfsParent |
gptkb:Newsweek
gptkb:The_March_of_Time gptkb:Connecticut |
| gptkbp:bfsLayer |
4
|